Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
30.8M
-
Number of holders
-
51
-
Total 13F shares, excl. options
-
3.42M
-
Shares change
-
-1.07M
-
Total reported value, excl. options
-
$10.1M
-
Value change
-
-$3.23M
-
Number of buys
-
26
-
Number of sells
-
-36
-
Price
-
$2.97
Significant Holders of XBiotech Inc. - Common Shares, no par value (XBIT) as of Q2 2025
69 filings reported holding XBIT - XBiotech Inc. - Common Shares, no par value as of Q2 2025.
XBiotech Inc. - Common Shares, no par value (XBIT) has 51 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.42M shares
of 30.8M outstanding shares and own 11.1% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (945K shares), MILLENNIUM MANAGEMENT LLC (551K shares), BlackRock, Inc. (374K shares), GEODE CAPITAL MANAGEMENT, LLC (221K shares), RBF Capital, LLC (200K shares), GOLDMAN SACHS GROUP INC (112K shares), NORTHERN TRUST CORP (93.2K shares), MORGAN STANLEY (85.8K shares), DIMENSIONAL FUND ADVISORS LP (71K shares), and STATE STREET CORP (68.5K shares).
This table shows the top 51 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.